anonymous
Guest
anonymous
Guest
FDA approves Lucemyra, first drug to curb opioid withdrawal symptoms.
Considering the severity of opioid addiction, the FDA had expedited the approval process. Kentucky-based US WorldMeds, the manufacture of Lucemyra, is required to conduct further clinical trials in young people and opioid-addicted mothers of newborns for long-term treatment. The privately held company is yet to price the new drug.
https://news.alphastreet.com/fda-approves-first-drug-to-curb-opioid-withdrawal-symptoms/
Considering the severity of opioid addiction, the FDA had expedited the approval process. Kentucky-based US WorldMeds, the manufacture of Lucemyra, is required to conduct further clinical trials in young people and opioid-addicted mothers of newborns for long-term treatment. The privately held company is yet to price the new drug.
https://news.alphastreet.com/fda-approves-first-drug-to-curb-opioid-withdrawal-symptoms/